Bortezomib
Bortezomib
- Classification\- Anticancer
What is Bortezomib?
It is a targeted anticancer medicine used widely for the treatment of blood cancer and cancer of the mantle cells.
Uses of Bortezomib
- Multiple Myeloma
- Mantle cell lymphoma
Working of Bortezomib
It causes protein buildup in the cells, stressing the cells and inhibiting cell growth.
Common side effects
- Nausea
- Vomiting
- Tiredness
- Low blood count
- Risk of infection
Serious side effects
- Bone marrow suppression
- Peripheral neuropathy
- Severe infections
- Bleeding
- Anemia
- Hypotension
- Cardiac arrhythmias or heart failure
- Respiratory distress
- Liver inflammation
- Renal dysfunctions
- Neurological conditions - confusion, headache, seizures
Precautions:
- To be used cautiously in
- Liver dysfunction
- Kidney disorders
- Elderly patients
- Heart problems
- Nerve problems
Contraindications
- Hypersensitivity or allergy to drug components.
- Pregnant and breastfeeding women
Warnings
- To be used under medical prescription.
- Herpes zoster reactivation
Important Monitoring Considerations
- Check for -
- Liver function - elevated liver enzymes
- Neurological conditions
- Cardiovascular functions
- Renal functions
- Infections
- Neuropathy assessment
- Electrolytes, uric acid
Gandhi Medicos - Your Trusted Source for Authentic Anticancer Medicines
At Gandhi Medicos, we are committed to delivering affordable, original, and WHO-GMP-certified cancer medicines across the globe.
Recognized as a super specialty pharmacy, we are trusted by patients, hospitals, and healthcare providers globally.
- ✅ Authentic & Verified Products
- ✅ WHO-GMP Certified Medicines
- ✅ Temperature-Controlled Shipments for sensitive medications
- ✅ Timely & Reliable Delivery
- ✅ Affordable Pricing - True Value for Money
- ✅ Global Reach - Serving 50+ Countries
- ✅ 2,500+ Satisfied Customers Worldwide
_"Delivering Trusted Health, Worldwide."_
Formulations based on "Bortezomib" (4)
Borviz 2.5mg Injection
Bortezomib (2.5mg)
Composition - Bortezomib 2.5 mg injection
Bortezomib
Bortezomib
It is a targeted anticancer medicine used widely for the treatment of blood cancer and cancer of the mantle cells.
Bortecad 2.5mg Injection
Bortezomib (2.5mg)
Multiple myeloma and mantle-cell lymphoma are both treated by Bortecad 2.5mg Injection. It demonstrates its efficacy by halting or reducing the proliferation of cancer cells.
Proteoz 2.5mg Injection
Bortezomib (2.5mg)
Multiple myeloma and mantle-cell lymphoma are both treated by Proteoz 2.5mg Injection. It demonstrates its efficacy by halting or reducing the proliferation of cancer cells.